McCarthy Teresa

Chief Human Resources Officer

McCarthy Teresa has filed 6 SEC Form 4 filings (10 transaction rows) across 2 companies, including RNAM, RNA, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Feb 27, 2026.

On the most recent filing, McCarthy Teresa is listed as Chief Human Resources Officer at Avidity Biosciences, Inc. Inside the rolling window, McCarthy Teresa reported no open-market purchases and 3 open-market sales totaling $1.4M in RNA. The largest disclosed transaction in the window is a sale of 20,000 RNA shares on Oct 15, 2025, worth $1.0M.

Companies traded

Other insiders at RNAM

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$1.4M

reported sales (SEC code S)

Companies

2

in the rolling window

Source
RNASale$212KJan 23SEC ↗
RNASale$142KJan 9SEC ↗
RNASale$1.0MOct 17SEC ↗
Showing 1–3 of 3
1 / 1

Earlier trades

Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.

DateTickerTypeValue
Sep 15, 2025RNASale$621K
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has McCarthy Teresa made?

McCarthy Teresa has filed 6 SEC Form 4 filings (10 transaction rows) across 2 companies, including RNAM, RNA since 2025.

Which companies does McCarthy Teresa trade?

McCarthy Teresa has filed SEC Form 4 disclosures for 2 companies, including RNAM, RNA.

When was McCarthy Teresa's most recent SEC Form 4 filing?

McCarthy Teresa's most recent SEC Form 4 filing on Tracefour is dated Feb 27, 2026.

What is McCarthy Teresa's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, McCarthy Teresa is listed as Chief Human Resources Officer.

What is McCarthy Teresa's total buy and sell value in the current window?

Inside the rolling retention window, McCarthy Teresa bought $0 and sold $1.4M based on SEC Form 4 filings.

What was McCarthy Teresa's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 20,000 RNA shares on 2025-10-15, worth $1.0M, per SEC Form 4 filings.